Bacopa BacoMind CDRI-08.
Bacopa BacoMind CDRI-08 supplementation for targeted health support. Enhances memory formation, improves information retention, and may reduce anxiety. Works by modulating acetylcholine and reducing oxidative stress in the brain.
Reviewed March 2026
- Category
- Adaptogen
What Bacopa BacoMind CDRI-08 is, and what it does.
- Does it work
- If you're patient and consistent. One of the better-studied natural memory supplements. Not for people who want instant results.
- How much to take
- 300mg BacoMind (CDRI-08) daily, standardized to 45% bacosides. Higher doses don't necessarily work better.
- Time to feel it
- Within the hours after a single dose.
- The first dose
- Day one is quiet, and stomach upset is the main thing people notice if they take it without food. The memory work accumulates across weeks rather than hours.
- With regular use
- After 8-12 weeks: improved memory, better recall, possibly reduced anxiety. Effects may continue to build over months.
- How well tolerated
- Generally well tolerated. GI upset is common. May affect thyroid and interact with sedatives.
- How it feels
- Subtle cognitive clarity over time. Better recall. Some people notice reduced anxiety.
- The overlooked benefit
- Gut bacteria strip the sugar groups off the bacosides before much gets absorbed, which is part of why the same dose lands differently from one person to the next.
150 to 300mg a day is where Bacopa BacoMind CDRI-08 works.
Source: Kongkeaw 2014 memory meta-analysis
In a double-blind, placebo-controlled crossover study, 24 healthy volunteers took placebo, 320 mg or 640 mg of a standardised Bacopa monnieri extract (CDRI 08) and then completed six repetitions of the Cognitive Demand Battery on the same day. The 320 mg dose raised performance at the first, second and fourth repetition after dosing; the treatments did not change cardiovascular activity or task-induced ratings of stress and fatigue. One crossover study in 24 people, and the authors state that an earlier pharmacological window was not assessed.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Improves memory formationMultiple meta-analyses
- Enhances learningStudent studies
- Reduces anxietySeveral RCTs
- Immediate cognitive boostRequires weeks of use
Questions people ask about Bacopa BacoMind CDRI-08.
- Why does it take so long to work?
- It changes brain chemistry gradually. Think of it like exercise for your neurons. Results come with consistency.
- BacoMind vs other bacopa extracts?
- BacoMind (CDRI-08) is a specific patented extract with clinical studies. Generic bacopa might work but has less research.
- Can I take it with other nootropics?
- Yes. Often combined with lion's mane, ginkgo, or racetams. No major interactions.
- Does it cause drowsiness?
- It can have mild calming effects. Usually not sedating, but some people take it at night.
- Well tolerated in students?
- Generally yes. Used traditionally for children in India. Good safety profile.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Bacopa's bacosides help maintain acetylcholine, the messenger tied to memory and learning, by tempering the enzyme that clears it, while alpha-GPC delivers the choline the body uses to build acetylcholine in the first place. The pair supports cholinergic signaling from both the supply and the turnover side.
Ginkgo supports blood flow to the brain and the delivery of oxygen and glucose that neurons run on, while bacopa supports cholinergic signaling and acts as an antioxidant in nerve tissue. Pairing them is a familiar way to cover circulation and neurotransmitter support in one formula.
Both are classical Medhya, or brain tonic, herbs that Ayurveda has paired for generations. Ashwagandha helps modulate the HPA axis that governs the body's stress response, supporting calm resilience, while bacopa supports memory and learning, so a single formula addresses stress load and cognition together.
Huperzine A inhibits acetylcholinesterase directly while bacosides are reported to modulate cholinergic signalling, so both push acetylcholine tone. The additive load is worth accounting for.
Choline is the rate-limiting substrate choline acetyltransferase uses to build acetylcholine, the transmitter bacosides act on. Substrate and modulator sit on the same pathway.
ALCAR carries an acetyl group that can be transferred toward acetyl-CoA and acetylcholine synthesis, a substrate role distinct from the cholinergic modulation attributed to bacosides.
Piperine from long pepper inhibits intestinal efflux transport and first-pass metabolism, which raises systemic exposure to saponins such as the bacosides.
Citicoline is cleaved to cytidine and choline, feeding both membrane phosphatidylcholine and the acetylcholine pool. Bacopa extracts are described as acting on cholinergic signalling and on acetylcholinesterase activity, so the two sit on the same system from different ends. The pairing is standard formulation logic; the combination itself has not been measured in a trial reported here.
Theanine acts quickly on glutamatergic and GABAergic tone and shifts alpha-band activity within an hour. Bacopa is a slow-building extract measured over weeks. Formulas pair them so that something is noticeable on day one while the extract accumulates, which is a sensible sequence rather than a demonstrated synergy.
Caffeine blocks adenosine receptors and its effect is felt in under an hour. Bacopa does nothing on that timescale, so anything a person feels on the first dose of a combined product is the caffeine. Worth saying plainly, because attributing the immediate lift to the extract is the usual error in this pairing.
Rhodiola is used for acute-load fatigue resistance and shows effects within days; bacopa is a multi-week memory-consolidation extract. Stacking them covers two different time courses in one product. The combination is a formulation convention and the two have not been tested together here.
Phosphatidylserine is a structural phospholipid of neuronal membranes and is used in cognitive formulas on that basis. Bacopa's saponins interact with membranes and cholinergic signalling. The pairing is mechanistically plausible and appears in commercial stacks, with no combination evidence to lean on.
DHA is the dominant long-chain polyunsaturated fat in synaptic membranes and influences membrane fluidity and receptor environment. A saponin-based extract acting at membranes and at cholinergic synapses works in that same physical context. Two separate contributions to normal cognitive function rather than one measured combined effect.
Piperine slows CYP3A4 and UDP-glucuronosyltransferase activity and inhibits P-glycoprotein, which raises systemic exposure to several co-administered plant compounds. Bacoside saponins are poorly absorbed, so the pairing is used to push exposure up. The enzyme effect is well established; the size of the change for bacosides specifically is not, and higher exposure also means a lower dose can behave like a larger one.
Hericium preparations are studied for neurotrophic signalling; bacopa work centres on cholinergic tone and memory consolidation. Different mechanisms in the same domain is the reason stacks combine them. This is formulation reasoning at low confidence with no combination data behind it.
Nothing specific on file for Bacopa BacoMind CDRI-08. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Bacopa BacoMind CDRI-08 actually does.
The characterised actives in Bacopa monnieri leaf are dammarane-type triterpenoid saponins, the bacosides, and a standardised extract is defined by the bacoside profile it is assayed to rather than by leaf weight.
Whole-leaf powder and a standardised extract are not interchangeable by weight: the extract concentrates the saponins several-fold, so a gram of powder and a gram of extract deliver very different bacoside amounts.
Bacoside saponins are large, amphiphilic and poorly absorbed intact, so oral exposure depends on formulation and on gut microbial deglycosylation of the sugar groups.
Preclinical work on bacopa extracts describes modulation of cholinergic signalling, including acetylcholinesterase activity, which is the mechanism most often used to explain effects on memory consolidation.
Getting Bacopa BacoMind CDRI-08 from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Pooling 29 randomised trials in 2,107 healthy adults, Bacopa monnieri at 600 mg a day or more improved working memory versus placebo, with a standardised mean difference of 2.03 (95% CI 1.28 to 2.78), while sustained attention, selective attention and processing speed showed no clear difference.Meta-analysis. Tiemtad et al., 2026 (Phytomedicine). PMID 41678913 ↗
- Across nine placebo-controlled trials of at least 12 weeks, pooling 437 analysed adults, standardised Bacopa monnieri extract shortened Trail Making B time by about 18 ms and choice reaction time by about 11 ms, which the authors read mainly as faster speed of attention.Meta-analysis. Kongkeaw et al., 2014 (Journal of Ethnopharmacology). PMID 24252493 ↗
- In 81 healthy adults over 55 who completed the study, the branded BacoMind extract at 300 mg a day for 12 weeks improved verbal learning, memory acquisition and delayed recall on the Rey Auditory Verbal Learning Test, with no significant change on the complex figure or trail-making tests and more digestive complaints than placebo.Randomised trial. Morgan and Stevens, 2010 (Journal of Alternative and Complementary Medicine). PMID 20590480 ↗
- In 24 healthy volunteers, a single 320 mg dose of the CDRI 08 extract improved scores on a demanding repeated cognitive battery at three of six post-dose repetitions, while the 640 mg dose and both doses on cardiovascular measures and task-induced stress and fatigue showed no detectable difference from placebo.Randomised trial. Downey et al., 2013 (Phytotherapy Research). PMID 23281132 ↗
- Reviewing the human and mechanistic literature, the authors report that Bacopa monnieri supplementation is most consistently linked to improvements in memory recall and information processing speed, alongside antioxidant activity in nerve tissue.Systematic review. Valotto Neto et al., 2024 (Antioxidants (Basel, Switzerland)). PMID 38671841 ↗
- In a review of botanicals used for mental performance, Bacopa monnieri had among the better-supported human evidence for memory measures, with reported side effects dominated by mild digestive complaints.Systematic review. Roe et al., 2021 (Current neuropharmacology). PMID 34315377 ↗
- This review of Bacopa monnieri extract reports that the bacoside fraction is the constituent credited with the observed effects on memory and attention, with benefit in trials generally appearing only after several weeks of daily use.Systematic review. Fatima et al., 2022 (Frontiers in nutrition). PMID 36061899 ↗
These are the studies our verdict leans on, chosen from the 565 we read for Bacopa BacoMind CDRI-08. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.